Assistant Professor of Medicine, Center for Individualized Medicine Microbiome Program, Mayo Clinic, Rochester, MN
Ruben Mars obtained his Ph.D. in Medical Microbiology from the University of Groningen in the Netherlands in 2014, where he worked on gene regulation in Gram-positive bacteria.
He moved on to a postdoc at ETH Zurich, Switzerland, where he used innovative untargeted metabolomics approaches to unravel microbe-microbe and microbe-host interactions. Towards the end of his tenure in Zurich, Ruben started consulting for multiple companies in the microbiome therapeutics space, including the Human Microbiome Institute of Johnson & Johnson. He then helped Medipredict, a consumer-focused personalized medicine startup from Budapest, Hungary, to develop their microbiome and metabolomics measurement and data interpretation pipeline.
In 2019, Ruben moved to the US and worked on multi-omics integration for a series of human microbiome projects at Mayo Clinic in Rochester, Minnesota.